• 1
    Kopelman, PG (2000) Obesity as a medical problem. Nature 404: 635643.
  • 2
    Klein, S. (2001) Outcome success in obesity. Obes Res. 9 (Suppl 4): 3548S.
  • 3
    Mann, JI (2000) Can dietary intervention produce long-term reduction in insulin resistance? Br J Nutr. 83 (Suppl 1): S169S172.
  • 4
    Curioni, C. C., Lourenco, PM (2005) Long-term weight loss after diet and exercise: a systematic review. Int J Obes. 29: 11681174.
  • 5
    Katz, DL (2005) Competing dietary claims for weight loss: finding the forest through truculent trees. Annu Rev Public Health 26: 6188.
  • 6
    Wing, R. R., Venditti, E., Jakicic, J. M., Polley, B. A., Lang, W. (1998) Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care 3: 350359.
  • 7
    Finer, N. (2002) Pharmacotherapy of obesity. Best Pract Res Clin Endocrinol Metab. 4: 717742.
  • 8
    Small, C. J., Bloom, SR (2004) Gut hormones and the control of appetite. Trends Endocrinol Metab. 6: 259263.
  • 9
    Woods, SC (2004) Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake. Am J Physiol Gastrointest Liver Physiol. 286: G7G13.
  • 10
    Elmquist, J. K., Flier, JS (2004) Neuroscience. The fat-brain axis enters a new dimension. Science 304: 6364.
  • 11
    Mercer, L. P., Kelley, D. S., Humphries, L. L., Dunn, JD (1994) Manipulation of central nervous system histamine or histaminergic receptors (H1) affects food intake in rats. J Nutr. 7: 10291036.
  • 12
    Haq, A. U., Bundrant, H. M., Mercer, LP (1996) Food intake is inversely correlated with central nervous system histamine receptor (H1) concentrations in male Sprague-Dawley rats fed normal, low protein, low energy or poor quality protein diets. J Nutr. 126: 30833089.
  • 13
    Ookuma, K., Yoshimatsu, H., Sakata, T., Fujimoto, K., Fukagawa, F. (1989) Hypothalamic sites of neuronal histamine action on food intake by rats. Brain Res. 2: 268275.
  • 14
    Arrang, J. M., Garbarg, M., Schwartz, JC (1983) Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302: 832837.
  • 15
    Lovenberg, T. W., Roland, B. L., Wilson, S. J., et al (1999) Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol. 6: 11011107.
  • 16
    Lovenberg, T. W., Pyati, J., Chang, H., Wilson, S. J., Erlander, MG (2000) Cloning of rat histamine H(3) receptor reveals distinct species pharmacological profiles. J Pharmacol Exp Ther. 293: 771778.
  • 17
    Malmlof, K., Zaragoza, F., Golozoubova, V., et al (2005) Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight. Int J Obes (Lond). 29: 14021412.
  • 18
    Hancock, A. A., Bennani, Y. L., Bush, E. N., et al (2004) Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist. Eur J Pharmacol. 487: 183197.
  • 19
    Zaragoza, F., Stephensen, H., Knudsen, S. M., Pridal, L., Wulff, B. S., Rimvall, K. (2004) 1-Alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists. J Med Chem. 47: 28332838.
  • 20
    Peschke, B., Bak, S., Hohlweg, R., et al (2004) Cinnamic amides of (S)–2–(aminomethyl)pyrrolidines are potent H3 antagonists. Bioorg Med Chem. 12: 26032616.
  • 21
    Wulff, B. S., Hastrup, S., Rimvall, K. (2002) Characteristics of recombinantly expressed rat and human histamine H3 receptors. Eur J Pharmacol. 453: 3341.
  • 22
    Malmlof, K., Johansen, T. (2003) Growth hormone-mediated breakdown of body fat: insulin and leptin responses to GH are modulated by diet composition and caloric intake in old rats. Hormone Met Res. 35: 236242.
  • 23
    Johansen, T., Deckert, M., Mandrup-Poulsen, T., Malmlof, K. (1999) The role of growth hormone and glucocorticoid in glucose handling in vivo. J Endocrinol. 162: 8793.
  • 24
    Williams, G., Bing, C., Cai, X. J., Harrold, J. A., King, P. J., Liu, XH (2001) The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol Behav. 74: 683701.
  • 25
    Hancock, A. A., Brune, ME (2005) Assessment of pharmacology and potential anti-obesity properties of H3 receptor antagonists/inverse agonists. Expert Opin Investig Drugs 14: 223241.
  • 26
    Sindelar, D. K., Shepperd, M. L., Pickard, R. T., et al (2004) Central H3R activation by thioperamide does not affect energy balance. Pharmacol Biochem Behav. 78: 275283.
  • 27
    Fontana, L., Meyer, T. E., Klein, S., Holloszy, JO (2004) Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci U S A. 101: 66596663.
  • 28
    Harder, H., Dinesen, B., Astrup, A. (2004) The effect of a rapid weight loss on lipid profile and glycemic control in obese type 2 diabetic patients. Int J Obes. 28: 180182.
  • 29
    Vaisman, N., Sklan, D., Dayan, Y. (1990) Effect of moderate semi-starvation on plasma lipids. Int J Obes. 14: 989996.
  • 30
    Davignon, J., Cohn, JS (1996) Triglycerides: a risk factor for coronary heart disease. Atherosclerosis. 124 (suppl): S57S64.
  • 31
    Krauss, RM (1998) Triglycerides and atherogenic lipoproteins: rationale for lipid management. Am J Med. 1A: 5862S.
  • 32
    Frayn, KN (2001) Adipose tissue and the insulin resistance syndrome. Proc Nutr Soc. 60: 375380.
  • 33
    Kelley, D. E., Goodpaster, B. H., Storlien, L. (2002) Muscle triglyceride and insulin resistance. Annu Rev Nutr. 22: 325346.
  • 34
    McGarry, JD (2002) Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51: 718.
  • 35
    Reaven, G. (2002) Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 106: 286288.
  • 36
    Teusink, B., Voshol, P. J., Dahlmans, V. E., et al (2003) Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake. Diabetes 3: 614620.
  • 37
    Griffiths, A. J., Humphreys, S. M., Clark, M. L., Fielding, B. A., Frayn, KN (1994) Immediate metabolic availability of dietary fat in combination with carbohydrate. Am J Clin Nutr. 59: 5359.
  • 38
    Tancredi, R. G., Dagenais, G. R., Zierler, KL (1976) Free fatty acid metabolism in the forearm at rest: muscle uptake and adipose tissue release of free fatty acids. Johns Hopkins Med J. 138: 167179.
  • 39
    Corton, J. C., Apte, U., Anderson, S. P., et al (2004) Mimetics of caloric restriction include agonists of lipid-activated nuclear receptors. J Biol Chem. 279: 4620446212.
  • 40
    Eaton, S. (2002) Control of mitochondrial beta-oxidation flux. Prog Lipid Res. 41: 197239.
  • 41
    Goodpaster, B. H., Kelley, D. E., Wing, R. R., Meier, A., Thaete, FL (1999) Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 48: 839847.
  • 42
    Mustonen, A-M, Pyykönen, T., Paakkonen, T., et al (2005) Adaptations to fasting in the American mink (Mustela vison): carbohydrate and lipid metabolism. Comp Biochem Physiol A Mol Integr Physiol. 140: 195202.
  • 43
    Randle, P. J., Garland, P. B., Hales, C. N., Newsholme, EA (1963) The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785789.
  • 44
    Boden, G., Shulman, GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest. 32 (Suppl 3): 1423.
  • 45
    Boden, G., Chen, X., Ruiz, J., White, J. V., Rossetti, L. (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest. 93: 24382446.
  • 46
    Tsuda, K., Yoshimatsu, H., Niijima, A., Chiba, S., Okeda, T., Sakata, T. (2002) Hypothalamic histamine neurons activate lipolysis in rat adipose tissue. Exp Biol Med. 227: 208213.